Welcome to Lynxee consulting's blog
This blog offers you the latest regulatory news in the plant protection sector. Posts have been compiled since 2015.15 April 2020
During the EFSA peer review of pesticide active substances under Regulation (EC) No. 1107/2009, several aspects in the area of mammalian toxicology were identified by EFSA […]
6 April 2020
In view of the current Covid-19 situation, ANSES has adapted its organisation to allow authorisation and parallel trade permit holders (plant protection products, fertilisers, adjuvants) to […]
3 April 2020
The national memo on sustainable management of fungicide resistance of Sclerotinia sclerotinium on oilseed rape has been published : Management of fungicides resistance used to control […]
31 March 2020
In accordance with CLP Regulation No. 1272/2008, any phytopharmaceutical product with an authorisation or a parallel trade permit must be classified by manufacturers. However, the classification […]
25 March 2020
As a result of the entry into force of Regulation (EU) 2019/1100 of 27 June 2019 concerning the non-renewal of desmedipham approval, ANSES has withdrawn, from […]
11 March 2020
Further to the publication of the Order of 27 February 2020 repealing the Order of 09 March 2016, the rate of the tax applied to the […]
3 March 2020
Two national memos on the sustainable management of resistance to fungicides were published: Management of resistance to fungicides used to control cereals diseases (in French) […]
28 February 2020
As a result of the entry into force of Regulations (EU) 2020/18 and 2020/17 of 10 January 2020 concerning respectively the non-renewal of chlorpyrifos and chlorpyrifos-methyl […]
28 February 2020
Guidance document SANTE/12682/2019 “Analytical quality control and method validation procedures for pesticide residues analysis in food and feed” supersedes guidance document SANTE/11813/2017 from 01 January 2020. […]
28 February 2020
The reference document of Good Experimental Practice (GEP) related to the accreditation to conduct officially recognised efficacy trials (Revision of 2 February 2020) supersedes the same […]